Nebivolol, an FDA-Approved Drug, Has General Antibacterial and Antibiofilm Effects and Increases <i>Pseudomonas aeruginosa</i> Tolerance to Ciprofloxacin

Nebivolol, an FDA-Approved Drug, Has General Antibacterial and Antibiofilm Effects and Increases <i>Pseudomonas aeruginosa</i> Tolerance to Ciprofloxacin

Background: The repurposing of approved drugs for new activities is gaining widespread attention, including drugs that have antibacterial properties. Nevertheless, besides the benefits of repurposing drugs, the discovery of new antibiotic activity in commonly used medicines raises concerns about ind...

Full description

Saved in:
Bibliographic Details
Main Authors: Yael Schlichter Kadosh, Noa Goorevitch, Kerem Teralı, Jacob Gopas, Ariel Kushmaro
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceuticals
Subjects:
nebivolol
FDA-approved drug
antibacterial resistance
<i>Pseudomonas aeruginosa</i>
biofilm
Online Access:https://www.mdpi.com/1424-8247/17/11/1472
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/17/11/1472

Similar Items